J4 ›› 2009, Vol. 35 ›› Issue (6): 1029-1031.

Previous Articles     Next Articles

Effect of polyi:c on angiogenesis in mouse prostate carcinoma tissue

 TIAN Yuan-tong1, ZHONG Yi2, ZENG Jing1, ZHAO Xue-Jian3, ZHAO Li-Juan3   

  1. (1. Department of Pharmacology,Gan Nan Medical School,Ganzhou 341000,China|2.Department of Urinary Surgery,People’s Hospital of Ganxian,Ganxian 341100,China;3.Department of Pathophysiology, School of Basic Medical Sciences,Jilin University,Changchun 130021,China)
  • Received:2009-07-13 Online:2009-11-28 Published:2009-11-28

Abstract:

Abstract:Objective To investigate the effects of polyi:c on angiogenesis in mouse prostate carcinoma tissue and their possible mechanisms.Methods Mouse prostate carcinoma models were randomly divided into two groups according to tumor weight:control group and polyi:c group.After  treatment for 7 times,the mice were sacrificed and the tumor tissues were cut for weighing,calculating the tumor inhibitory rate and tumor index.Hematoxylin-eosin staining and immunohistochemical staining were performed to observate the morphological changes of prostate carcinoma tissues,distribution of vasa and expressions of vascular endothelial growth factor (VEGF) and endothelial nitric-oxide synthase (eNOS).
Results In polyi:c group,the mean tumor inhibitory rate was 67.85% and the tumor index was(5.42±0.17)%;in control group,the tumor index was(14.45±1.06)%;  there was significant differences between polyi:c group and control group( P<0.01). The expressions of VEGF in polyi:c group and control group were (9.64±2.90)% and (37.91±7.62)%, respectively,and there was significant difference between two groups( P<0.01). The expressions of eNOS in polyi:c group and control group were (4.43±10.39)% and (22.00±8.07)%,respectively,and there was significant difference between two groups ( P<0.01).Conclusion Through decreasing the expressions of VEGF
and eNOS,polyi:c plays an important role in inhibitting the angiogenesis and indirect inhibiting mouse prostate carcinoma.

Key words: polvriboinsine-polyribocyaidylic acid;prostaic neoplasms;vascular endothelial growth factor;endothelial nitric-oxide synthase  

CLC Number: 

  • R73-36